These include improving oxidative phosphorylation, treating with insulin or other diabetes drugs that increase insulin sensitivity, as well as small molecules that correct mitochondrial dysfunction, ketone-based interventions, RNA therapeutics and multimodal lifestyle changes [48]. The gene discussed is INS; the disease is diabetes mellitus.